Many patients experience improvements in: Type 2 diabetes Prediabetes Blood pressure Cholesterol Fatty liver disease Sleep apnea Joint pain Mobility Energy levels Quality of life Some GLP-1 medications have also demonstrated cardiovascular and kidney benefits in people with type 2 diabetes and established cardiovascular disease
Evaluation Includes: Reviewing medical and weight loss history, including GLP-1 use and rate of weight reduction
People with weakness, numbness, gait problems, or persistent fatigue may need broader testing because similar symptoms can come from many causes
Symptoms of hypoglycemia: Shakiness, trembling Sweating, cold skin Rapid heartbeat Confusion, difficulty concentrating Dizziness, lightheadedness Hunger, nausea Prevention protocol: 1
CAS No.: 289711-21-3 Formula: C 16 H 28 N 4 O 7 S 3 Molecular Weight:484.61 Storage: Please store the product under the recommended conditions in the Certificate of Analysis
Wadden, S